Fig. 1From: Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathwayFucoidan inhibited viability and proliferation of prostate cancer cells. DU-145 cells were treated with 100, 200, 500, 1000 μg/mL of fucoidan for 24 h. Cell viability (a) and proliferation (b) were measured by MTT and BrdU incorporation assay, respectively. ** P < 0.01 vs. control, *** P < 0.001 vs. control. All experiments were repeated at least three timesBack to article page